UCSF researchers have safely transplanted a woman’s stem cells into her growing fetus, leading to the live birth of an infant with a normally fatal fetal condition.

By studying a rare liver disease called Alagille syndrome, scientists from UC San Francisco and Cincinnati Children’s Hospital Medical Center have discovered the mechanism behind an unusual form of tissue regeneration that may someday reduce the need for expensive and difficult-to-obtain organ transplants.

Severe combined immunodeficiency (SCID) if undetected can be lethal by the time a child turns 1 year old. UCSF researchers created a screening test for SCID, which impacts Navajo families at a far higher rate than the rest of the population.

An easy-to-use tool to predict the likelihood of a child with kidney disease progressing to kidney failure has a high degree of accuracy.

A virus hiding quietly in the gut may trigger the onset of a severe complication known as graft-versus-host disease (GvHD) in patients who receive bone marrow transplants.

Through years of research and advocacy, Peter Stock, a transplant surgeon at UCSF, helped clear the way for California’s first organ transplants from an HIV-positive donor to HIV-positive recipients.

By piercing liver cells with rapid pulses of electricity, scientists at UC San Francisco have demonstrated an entirely new way to transplant cells into organs to treat disease.